Long-term efficacy of combination therapy with PEG-IFN and entecavir on HBsAg loss and anti-HBs seroconversion in patients with chronic active hepatitis

Aladag, MuratAladag, HulyaHarputluoglu, MuratSeckin, YukselBilgic, YilmazKarincaoglu, Melih2024-08-042024-08-0420120270-9139https://hdl.handle.net/11616/10362463rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) -- NOV 09-13, 2012 -- Boston, MA[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Long-term efficacy of combination therapy with PEG-IFN and entecavir on HBsAg loss and anti-HBs seroconversion in patients with chronic active hepatitisConference Object56531A531AWOS:000310955602087Q1